Safety and Efficacy of Antiplatelet and Antithrombotic Therapy in Acute Coronary Syndrome Patients With Chronic Kidney Disease

被引:46
作者
Basra, Sukhdeep S. [2 ]
Tsai, Peter [3 ]
Lakkis, Nasser M. [1 ,2 ]
机构
[1] Baylor Coll Med, Cardiol Sect, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA
[3] Baylor Coll Med, Sect Cardiothorac Surg, Dept Surg, Houston, TX 77030 USA
关键词
acute coronary syndrome(s); antiplatelet; antithrombotic; bleeding; chronic kidney disease; non-ST-segment elevation myocardial infarction; ST-segment elevation myocardial infarction; unstable angina; ST-SEGMENT ELEVATION; WAVE MYOCARDIAL-INFARCTION; MOLECULAR-WEIGHT HEPARIN; STAGE RENAL-DISEASE; HIGH-RISK PATIENTS; GLYCOPROTEIN IIB/IIIA INHIBITORS; UNFRACTIONATED HEPARIN; ARTERY-DISEASE; DOUBLE-BLIND; PLATELET INHIBITION;
D O I
10.1016/j.jacc.2011.08.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is prevalent and affects an ever-increasing proportion of patients presenting with acute coronary syndrome (ACS). Patients with CKD have a higher risk of ACS and significantly higher mortality, and are also predisposed to increased bleeding complications. Antiplatelet and antithrombotic drugs form the bedrock of management of patients with ACS. Most randomized trials of these drugs exclude patients with CKD, and current guidelines for management of these patients are largely based on these trials. We aim to review the safety and efficacy of these drugs in patients with CKD presenting with ACS. (J Am Coll Cardiol 2011;58:2263-9) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:2263 / 2269
页数:7
相关论文
共 71 条
[1]   Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes [J].
Al Suwaidi, J ;
Reddan, DN ;
Williams, K ;
Pieper, KS ;
Harrington, RA ;
Califf, RM ;
Granger, CB ;
Ohman, EM ;
Holmes, DR .
CIRCULATION, 2002, 106 (08) :974-980
[2]  
Alam Mahboob, 2009, Am Heart Hosp J, V7, P17
[3]   Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].
Alexander, John H. ;
Becker, Richard C. ;
Bhatt, Deepak L. ;
Cools, Frank ;
Crea, Filippo ;
Dellborg, Mikael ;
Fox, Keith A. A. ;
Goodman, Shaun G. ;
Harrington, Robert A. ;
Huber, Kurt ;
Husted, Steen ;
Lewis, Basil S. ;
Lopez-Sendon, Jose ;
Mohan, Puneet ;
Montalescot, Gilles ;
Ruda, Mikhail ;
Ruzyllo, Witold ;
Verheugt, Freek ;
Wallentin, Lars ;
Darius, Harald ;
Simoons, Maarten ;
Boersma, Eric ;
DeLemos, James ;
Spencer, Fred .
CIRCULATION, 2009, 119 (22) :2877-U39
[4]   Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes [J].
Alexander, KP ;
Chen, AY ;
Roe, MT ;
Newby, LK ;
Gibson, CM ;
Allen-LaPointe, NM ;
Pollack, C ;
Gibler, WB ;
Ohman, EM ;
Peterson, ED .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (24) :3108-3116
[5]   ACC/AHA 2007 guide lines for the management of patients with unstable Angina/Non-ST-Elevation myocardial infraction - Executive summary [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E., II ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Smith, Sidney C., Jr. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Riegel, Barbara .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (07) :652-726
[6]   Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy [J].
Angiolillo, Dominick J. ;
Bernardo, Esther ;
Capodanno, Davide ;
Vivas, David ;
Sabate, Manel ;
Ferreiro, Jose Luis ;
Ueno, Masafumi ;
Jimenez-Quevedo, Pilar ;
Alfonso, Fernando ;
Bass, Theodore A. ;
Macaya, Carlos ;
Fernandez-Ortiz, Antonio .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) :1139-1146
[7]  
[Anonymous], 2000, LANCET, V356, P2037
[8]  
[Anonymous], 2002, AM J KIDNEY DIS
[9]  
[Anonymous], BMJ
[10]  
Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014